Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation, 60919-60923 [2024-16589]
Download as PDF
60919
Federal Register / Vol. 89, No. 145 / Monday, July 29, 2024 / Notices
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on June 12, 2024, Galephar
Pharmaceutical Research Inc, #100 Carr
198 Industrial Park, Juncos, Puerto Rico
00777–3873 applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
ddrumheller on DSK120RN23PROD with NOTICES1
Hydromorphone .............
Morphine ........................
I
9150
9300
Schedule
I
II
II
The company plans to import the
listed controlled substances for
analytical purposes only. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–16588 Filed 7–26–24; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:51 Jul 26, 2024
Jkt 262001
DEPARTMENT OF JUSTICE
Controlled substance
Drug
code
Schedule
7315
I
7431
I
7437
7438
9780
I
I
II
Drug Enforcement Administration
[Docket No. DEA–1396]
Importer of Controlled Substances
Application: Catalent Pharma
Solutions, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Catalent Pharma Solutions,
LLC has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 28, 2024. Such
persons may also file a written request
for a hearing on the application on or
before August 28, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 5, 2024, Catalent
Pharma Solutions, LLC, 3031 Red Lion
Road, Philadelphia, Pennsylvania
19114–1123, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Lysergic acid
diethylamide.
5-Methoxy-N, Ndimethyltryptamine.
Psilocybin ........................
Psilocyn ...........................
Tapentadol ......................
The company plans to import the
listed controlled substances as finished
dosage unit products for clinical trials,
research, and analytical activities. No
other activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–16587 Filed 7–26–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1398]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cerilliant Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 27, 2024. Such
persons may also file a written request
for a hearing on the application on or
before September 27, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
SUMMARY:
E:\FR\FM\29JYN1.SGM
29JYN1
60920
Federal Register / Vol. 89, No. 145 / Monday, July 29, 2024 / Notices
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on June 20, 2024,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402 applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ......................................................................................................................
Cathinone ................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ......................................................................................................................
Para-Methoxymethamphetamine (PMMA), 1-(4- 1245 I N methoxyphenyl)-N-methylpropan-2-amine ..................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ........................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine ...............................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Fenethylline .............................................................................................................................................................
Aminorex .................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- 1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ........................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ...................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ..........................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ..................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ........
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...........................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .........................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .........
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..............
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .......................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ...............................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...............
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .........................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) .................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .......................................
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..........................
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ........................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate)
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ....................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ............................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...........................................................................................
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ..............
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .........
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) .............................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..............................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..........................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
VerDate Sep<11>2014
18:51 Jul 26, 2024
Jkt 262001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\29JYN1.SGM
29JYN1
Schedule
1233
1235
1237
1238
1245
1246
1248
1249
1258
1475
1478
1480
1503
1585
1590
1595
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2010
2565
2780
2785
2786
2788
2789
6250
7008
7010
7011
7012
7014
7019
7020
7021
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
I
I
I
I
I
I
I
I
I
I
I
7043
I
7044
7047
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
I
I
I
I
I
I
I
60921
Federal Register / Vol. 89, No. 145 / Monday, July 29, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ..................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..........................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................................
4-MEAP (4-Methyl-alpha-ethylaminopentiophenone) ..............................................................................................
N-Ethylhexedrone ....................................................................................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) ...............................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................
Lysergic acid diethylamide ......................................................................................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .........................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Parahexyl .................................................................................................................................................................
Mescaline ................................................................................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) .....................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Bufotenine ...............................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin ................................................................................................................................................................
Psilocyn ...................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................
4′-Chloro-alpha-pyrrolidinovalerophenone ..............................................................................................................
MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ...................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
N-Benzylpiperazine .................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .............................................................................................
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ..........................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ..............................................................................................
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) ...........................................................................................................
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ..................................................................................................
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ............................................................................................
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .............................................................................................
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ......................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .............................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .............................................
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .............................................
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .............................................
a-PHP, alpha-Pyrrolidinohexanophenone ...............................................................................................................
Slpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
Alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
Ethylone ...................................................................................................................................................................
PV8, alpha-Pyrrolidinoheptaphenone ......................................................................................................................
Eutylone ...................................................................................................................................................................
a-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) ...................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................
Acetyldihydrocodeine ..............................................................................................................................................
Benzylmorphine .......................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................
Desomorphine .........................................................................................................................................................
VerDate Sep<11>2014
18:51 Jul 26, 2024
Jkt 262001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
E:\FR\FM\29JYN1.SGM
29JYN1
7203
7221
7222
7225
7245
7246
7249
7260
7286
7297
7298
7315
7348
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7548
7549
7551
7694
9051
9052
9053
9055
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
60922
Federal Register / Vol. 89, No. 145 / Monday, July 29, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Codeine methylbromide ...........................................................................................................................................
Brorphine .................................................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Difenoxin ..................................................................................................................................................................
Heroin ......................................................................................................................................................................
Hydromorphinol .......................................................................................................................................................
Methyldesorphine ....................................................................................................................................................
Methyldihydromorphine ...........................................................................................................................................
Morphine methylbromide .........................................................................................................................................
Morphine methylsulfonate .......................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................
Normorphine ............................................................................................................................................................
Pholcodine ...............................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .......................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..........................................................
MT-5 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .............................................................................................
Acetylmethadol ........................................................................................................................................................
Allylprodine ..............................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................
Alphameprodine ......................................................................................................................................................
Alphamethadol .........................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................
Betameprodine ........................................................................................................................................................
Betamethadol ..........................................................................................................................................................
Betaprodine .............................................................................................................................................................
Isotonitazene ...........................................................................................................................................................
Dipipanone ..............................................................................................................................................................
Etonitazene ..............................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................
Noracymethadol ......................................................................................................................................................
Norlevorphanol ........................................................................................................................................................
Normethadone .........................................................................................................................................................
Trimeperidine ...........................................................................................................................................................
Phenomorphan ........................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................
Tilidine .....................................................................................................................................................................
xybenzyl)-5-nitro1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) ........................................................................
-(2-(4-fluorobenzyl)-5- nitro1H-benzimidazol-1-yl)ethan-1- amine) .........................................................................
Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5- nitro-1Hbenzimidazol-1-yl)ethan-1-amine) .......................
N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)1Hbenzimidazole).
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine) ......................
Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)- 1H-benzimidazol-1- yl)ethan-1-amine) ...........................
Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) ....................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................
Para-Methylfentanyl .................................................................................................................................................
4′-Methyl Acetyl Fentanyl ........................................................................................................................................
Ortho-Methyl Methoxyacetyl Fentanyl .....................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................
Butyryl Fentanyl .......................................................................................................................................................
Para-fluorobutyryl fentanyl .......................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................
Para-chloroisobutyryl fentanyl .................................................................................................................................
Isobutyryl fentanyl ...................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................
3-Methylthiofentanyl ................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................
Thiofentanyl .............................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................
Para-methoxybutyryl fentanyl ..................................................................................................................................
Ocfentanil ................................................................................................................................................................
Thiofuranyl Fentanyl ................................................................................................................................................
Valeryl fentanyl ........................................................................................................................................................
Phenyl Fentanyl .......................................................................................................................................................
Beta′-Phenyl Fentanyl .............................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................
VerDate Sep<11>2014
18:51 Jul 26, 2024
Jkt 262001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\29JYN1.SGM
29JYN1
Schedule
9070
9098
9145
9168
9200
9301
9302
9304
9305
9306
9307
9313
9314
9547
9551
9560
9601
9602
9603
9604
9605
9607
9608
9609
9611
9614
9622
9624
9627
9633
9634
9635
9646
9647
9661
9750
9751
9756
9757
9758
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
9759
9764
9765
9811
9812
9813
9814
9815
9816
9817
9819
9820
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9839
9840
9841
9842
9843
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
60923
Federal Register / Vol. 89, No. 145 / Monday, July 29, 2024 / Notices
Controlled substance
Drug code
ddrumheller on DSK120RN23PROD with NOTICES1
Crotonyl Fentanyl ....................................................................................................................................................
Cyclopropyl Fentanyl ...............................................................................................................................................
Ortho-Fluorobutyryl Fenanyl ....................................................................................................................................
Cyclopentyl fentanyl ................................................................................................................................................
Ortho-Methyl Acetylfentanyl ....................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .............................................................................
Fentanyl Carbamate ................................................................................................................................................
Ortho-Fluoroacryl Fentanyl ......................................................................................................................................
Ortho-Fluoroisobutyryl Fentanyl ..............................................................................................................................
Para-Fluoro Furanyl Fentanyl ..................................................................................................................................
2′-Fluoro Ortho-Fluorofentanyl ................................................................................................................................
Beta-Methyl Fentanyl ..............................................................................................................................................
8Amphetamine ........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Phenmetrazine ........................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Amobarbital .............................................................................................................................................................
Pentobarbital ...........................................................................................................................................................
Secobarbital .............................................................................................................................................................
Glutethimide ............................................................................................................................................................
Nabilone ..................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................
Phencyclidine ..........................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .............................................................................................................
Norfentanyl ..............................................................................................................................................................
Phenylacetone .........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................
Alphaprodine ...........................................................................................................................................................
Cocaine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ..............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Hydrocodone ...........................................................................................................................................................
Levomethorphan ......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Isomethadone ..........................................................................................................................................................
Meperidine ...............................................................................................................................................................
Meperidine intermediate-A ......................................................................................................................................
Meperidine intermediate-B ......................................................................................................................................
Meperidine intermediate-C ......................................................................................................................................
Metazocine ..............................................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Thiafentanil ..............................................................................................................................................................
Racemethorphan .....................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ...............................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates and analytical reference
standards for sale to its customers. In
reference to drug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
VerDate Sep<11>2014
18:51 Jul 26, 2024
Jkt 262001
plans to bulk manufacture these drugs
as synthetic. No other activities for these
PO 00000
9844
9845
9846
9847
9848
9850
9851
9852
9853
9854
9855
9856
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8366
8501
8603
9010
9041
9050
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9273
9300
9333
9648
9652
9668
9729
9732
9737
9739
9740
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
drug codes are authorized for this
registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–16589 Filed 7–26–24; 8:45 am]
BILLING CODE P
Frm 00069
Fmt 4703
Sfmt 9990
E:\FR\FM\29JYN1.SGM
29JYN1
Agencies
[Federal Register Volume 89, Number 145 (Monday, July 29, 2024)]
[Notices]
[Pages 60919-60923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16589]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1398]
Bulk Manufacturer of Controlled Substances Application:
Cerilliant Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
September 27, 2024. Such persons may also file a written request for a
hearing on the application on or before September 27, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow
[[Page 60920]]
the online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on June 20, 2024, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402 applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3- 1233 I
FMC).
Cathinone....................... 1235 I
Methcathinone................... 1237 I
4-Fluoro-N-methylcathinone (4- 1238 I
FMC).
Para-Methoxymethamphetamine 1245 I
(PMMA), 1-(4- 1245 I N
methoxyphenyl)-N-methylpropan-2-
amine.
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4- 1249 I
MEC).
Naphyrone....................... 1258 I
N-Ethylamphetamine.............. 1475 I
Methiopropamine (N-methyl-1- 1478 I
(thiophen-2-yl)propan-2-amine.
N,N-Dimethylamphetamine......... 1480 I
Fenethylline.................... 1503 I
Aminorex........................ 1585 I
4-Methylaminorex (cis isomer)... 1590 I
4,4'-Dimethylaminorex (4,4'- 1595 I
DMAR; 4,5-dihydro-4- 1595 I N
methyl-5-(4-methylphenyl)-2-
oxazolamine; 4-methyl-5- (4-
methylphenyl)-4,5-dihydro-1,3-
oxazol-2-amine).
Gamma Hydroxybutyric Acid....... 2010 I
Methaqualone.................... 2565 I
Etizolam (4-(2-chlorophenyl)-2- 2780 I
ethyl-9-methyl-6H-thieno[3,2-
f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2- 2785 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1- 2786 I
methyl-8-nitro-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2- 2788 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro- 2789 I
5-(2-chlorophenyl)-1-methyl-1,3-
dihydro-2H-
benzo[e][1,4]diazepin-2-one.
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3- 7010 I
dimethyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanon
e.
AB-FUBINACA (N-(1-amino-3-methyl- 7012 I
1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H- 7014 I
indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanon
e).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB- 7021 I
FUBINACA (2-(1-(4-fluorobenzyl)-
1Hindazole-3-carboxamido)-3-
methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone).
5F-AB-PINACA (N-(1-amino-3- 7025 I
methyl-1-oxobutan-2-yl)-1-(5-
fluropentyl)-1H-indazole-3-
carboximide).
AB-CHMINACA (N-(1-amino-3-methyl- 7031 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-
3-carboxamide).
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-
3-carboxamide).
5F-AMB (Methyl 2-(1-(5- 7033 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3-methylbutanoate).
5F-ADB, 5F-MDMB-PINACA (Methyl 2- 7034 I
(1-(5-fluoropentyl)-1H-indazole-
3-carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3- 7035 I
dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5- 7036 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5- 7041 I
fluoropentyl)-1H-indole-3-
carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA 7042 I
(Methyl 2-(1-(cyclohexylmethyl)-
1H-indole-3-carboxamido)-3,3-
dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA 7043 I
or methyl 2- (1-(4-fluorobutyl)-
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2- 7044 I
(1-(cyclohexylmethyl)-1H-indole-
3-carboxamido)-3-
methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N- 7047 I
(4-FLUOROBENZYL) (N-(adamantan-
1-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboximide).
APINACA and AKB48 (N-(1- 7048 I
Adamantyl)-1-pentyl-1H-indazole-
3-carboxamide).
5F-APINACA, 5F-AKB48 (N- 7049 I
(adamantan-1-yl)-1-(5-
fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5- 7083 I
fluoropentyl)-N-(2-phenylpropan-
2-yl)-1H-indazole-3-
carboxamide).
5F-CUMYL-P7AICA (1-(5- 7085 I
fluoropentyl)-N-(2-phenylpropan-
2-yl)-1H-pyrrolo[2,3-b]pyridine-
3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano- 7089 I
CUMYL-BUTINACA, 4-CN-CUMYL
BINACA, CUMYL-4CN-BINACA, SGT-
78 (1-(4-cyanobutyl)-N-(2-
phenylpropan-2-yl)-1H-indazole-
3-carboxamide).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanon
e.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4- 7200 I
Morpholinyl)ethyl]-3-(1-
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
[[Page 60921]]
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 7221 I
1-(5-fluoropentyl)-1H-indole-3-
carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone................ 7246 I
Alpha-ethyltryptamine........... 7249 I
Ibogaine........................ 7260 I
2-(ethylamino)-2-(3- 7286 I
methoxyphenyl)cyclohexan-1-one
(methoxetamine).
CP-47,497 (5-(1,1- 7297 I
Dimethylheptyl)-2-[(1R,3S)-3-
hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide...... 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana....................... 7360 I
Tetrahydrocannabinols........... 7370 I
Parahexyl....................... 7374 I
Mescaline....................... 7381 I
2C-T-2 (2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine..... 7390 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5- 7395 I
dimethoxyamphetamine.
2,5-Dimethoxyamphetamine........ 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine 7399 I
3,4-Methylenedioxyamphetamine... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4- 7405 I
Methylenedioxymethamphetamine.
4-Methoxyamphetamine............ 7411 I
5-Methoxy-N-N-dimethyltryptamine 7431 I
Alpha-methyltryptamine.......... 7432 I
Bufotenine...................... 7433 I
Diethyltryptamine............... 7434 I
Dimethyltryptamine.............. 7435 I
Psilocybin...................... 7437 I
Psilocyn........................ 7438 I
5-Methoxy-N,N- 7439 I
diisopropyltryptamine.
4'-Chloro-alpha- 7443 I
pyrrolidinovalerophenone.
MPHP, 4'-Methyl-alpha- 7446 I
pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine. 7455 I
1-(1- 7458 I
Phenylcyclohexyl)pyrrolidine.
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine.............. 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4- 7508 I
methylphenyl) ethanamine).
2C-E (2-(2,5-Dimethoxy-4- 7509 I
ethylphenyl) ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine).
2C-I 2-(4-iodo-2,5- 7518 I
dimethoxyphenyl) ethanamine).
2C-C 2-(4-Chloro-2,5- 7519 I
dimethoxyphenyl) ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
25B-NBOMe (2-(4-bromo-2,5- 7536 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5- 7537 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5- 7538 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone........................ 7541 I
Pentylone....................... 7542 I
N-Ethypentylone, ephylone (1- 7543 I
(1,3-benzodioxol-5-yl)-2-
(ethylamino)-pentan-1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
Slpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
Alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
Ethylone........................ 7547 I
PV8, alpha- 7548 I
Pyrrolidinoheptaphenone.
Eutylone........................ 7549 I
[alpha]-PiHP (4-methyl-1-phenyl- 7551 I
2-(pyrrolidin-1-yl)pentan-1-
one).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine............ 9051 I
Benzylmorphine.................. 9052 I
Codeine-N-oxide................. 9053 I
Desomorphine.................... 9055 I
[[Page 60922]]
Codeine methylbromide........... 9070 I
Brorphine....................... 9098 I
Dihydromorphine................. 9145 I
Difenoxin....................... 9168 I
Heroin.......................... 9200 I
Hydromorphinol.................. 9301 I
Methyldesorphine................ 9302 I
Methyldihydromorphine........... 9304 I
Morphine methylbromide.......... 9305 I
Morphine methylsulfonate........ 9306 I
Morphine-N-oxide................ 9307 I
Normorphine..................... 9313 I
Pholcodine...................... 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]
benzamide)).
MT-5 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol.................. 9601 I
Allylprodine.................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine.................. 9604 I
Alphamethadol................... 9605 I
Betacetylmethadol............... 9607 I
Betameprodine................... 9608 I
Betamethadol.................... 9609 I
Betaprodine..................... 9611 I
Isotonitazene................... 9614 I
Dipipanone...................... 9622 I
Etonitazene..................... 9624 I
Hydroxypethidine................ 9627 I
Noracymethadol.................. 9633 I
Norlevorphanol.................. 9634 I
Normethadone.................... 9635 I
Trimeperidine................... 9646 I
Phenomorphan.................... 9647 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
Tilidine........................ 9750 I
xybenzyl)-5-nitro1Hbenzimidazol- 9751 I
1-yl)-N,N-diethylethan-1-
amine).
-(2-(4-fluorobenzyl)-5- nitro1H- 9756 I
benzimidazol-1-yl)ethan-1-
amine).
Metonitazene (N,N-diethyl-2-(2- 9757 I
(4- methoxybenzyl)-5- nitro-
1Hbenzimidazol-1-yl)ethan-1-
amine).
N-pyrrolidino etonitazene; 9758 I
etonitazepyne (2-(4-
ethoxybenzyl)-5-nitro-1-(2-
(pyrrolidin-1-yl)ethyl)-
1Hbenzimidazole).
Protonitazene (N,N-diethyl-2-(5- 9759 I
nitro-2-(4- propoxybenzyl)-1H-
benzimidazol-1- yl)ethan-1-
amine).
Metodesnitazene (N,N-diethyl-2- 9764 I
(2-(4- methoxybenzyl)- 1H-
benzimidazol-1- yl)ethan-1-
amine).
Etodesnitazene; etazene (2-(2-(4- 9765 I
ethoxybenzyl)- 1Hbenzimidazol-1-
yl)-N,N-diethylethan-1- amine).
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl............. 9812 I
3-Methylfentanyl................ 9813 I
Alpha-methylfentanyl............ 9814 I
Acetyl-alpha-methylfentanyl..... 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-
yl)propionamide.
Para-Methylfentanyl............. 9817 I
4'-Methyl Acetyl Fentanyl....... 9819 I
Ortho-Methyl Methoxyacetyl 9820 I
Fentanyl.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl................ 9822 I
Para-fluorobutyryl fentanyl..... 9823 I
4-Fluoroisobutyryl fentanyl (N- 9824 I
(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1- 9825 I
phenethylpiperidin-4-yl)-N-
phenylacetamide.
Para-chloroisobutyryl fentanyl.. 9826 I
Isobutyryl fentanyl............. 9827 I
Beta-hydroxyfentanyl............ 9830 I
Beta-hydroxy-3-methylfentanyl... 9831 I
Alpha-methylthiofentanyl........ 9832 I
3-Methylthiofentanyl............ 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl.................... 9835 I
Beta-hydroxythiofentanyl........ 9836 I
Para-methoxybutyryl fentanyl.... 9837 I
Ocfentanil...................... 9838 I
Thiofuranyl Fentanyl............ 9839 I
Valeryl fentanyl................ 9840 I
Phenyl Fentanyl................. 9841 I
Beta'-Phenyl Fentanyl........... 9842 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
[[Page 60923]]
Crotonyl Fentanyl............... 9844 I
Cyclopropyl Fentanyl............ 9845 I
Ortho-Fluorobutyryl Fenanyl..... 9846 I
Cyclopentyl fentanyl............ 9847 I
Ortho-Methyl Acetylfentanyl..... 9848 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11(h).
Fentanyl Carbamate.............. 9851 I
Ortho-Fluoroacryl Fentanyl...... 9852 I
Ortho-Fluoroisobutyryl Fentanyl. 9853 I
Para-Fluoro Furanyl Fentanyl.... 9854 I
2'-Fluoro Ortho-Fluorofentanyl.. 9855 I
Beta-Methyl Fentanyl............ 9856 I
8Amphetamine.................... 1100 II
Methamphetamine................. 1105 II
Lisdexamfetamine................ 1205 II
Phenmetrazine................... 1631 II
Methylphenidate................. 1724 II
Amobarbital..................... 2125 II
Pentobarbital................... 2270 II
Secobarbital.................... 2315 II
Glutethimide.................... 2550 II
Nabilone........................ 7379 II
1-Phenylcyclohexylamine......... 7460 II
Phencyclidine................... 7471 II
ANPP (4-Anilino-N-phenethyl-4- 8333 II
piperidine).
Norfentanyl..................... 8366 II
Phenylacetone................... 8501 II
1- 8603 II
Piperidinocyclohexanecarbonitri
le.
Alphaprodine.................... 9010 II
Cocaine......................... 9041 II
Codeine......................... 9050 II
Dihydrocodeine.................. 9120 II
Oxycodone....................... 9143 II
Hydromorphone................... 9150 II
Diphenoxylate................... 9170 II
Ecgonine........................ 9180 II
Ethylmorphine................... 9190 II
Hydrocodone..................... 9193 II
Levomethorphan.................. 9210 II
Levorphanol..................... 9220 II
Isomethadone.................... 9226 II
Meperidine...................... 9230 II
Meperidine intermediate-A....... 9232 II
Meperidine intermediate-B....... 9233 II
Meperidine intermediate-C....... 9234 II
Metazocine...................... 9240 II
Methadone....................... 9250 II
Methadone intermediate.......... 9254 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................ 9300 II
Thebaine........................ 9333 II
Levo-alphacetylmethadol......... 9648 II
Oxymorphone..................... 9652 II
Noroxymorphone.................. 9668 II
Thiafentanil.................... 9729 II
Racemethorphan.................. 9732 II
Alfentanil...................... 9737 II
Remifentanil.................... 9739 II
Sufentanil...................... 9740 II
Carfentanil..................... 9743 II
Tapentadol...................... 9780 II
Fentanyl........................ 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates and analytical reference
standards for sale to its customers. In reference to drug codes 7360
(Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to
bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-16589 Filed 7-26-24; 8:45 am]
BILLING CODE P